Wu, P, Kwok, C, Haththotuwa, R, Kontronias, R, Babu, A, Fryer, A, Myint, P, Chew-Graham, C and Mamas, M (2016) Pre-eclampsia is associated with a two-fold increase in diabetes: a systematic review and meta-analysis. Diabetologia, 59. pp. 2518-2526. ISSN 0012-186X

[thumbnail of Fig 1.docx] Text
Fig 1.docx - Accepted Version

Download (62kB)
[thumbnail of PET-DM manuscript Second resubmission Final.docx] Text
PET-DM manuscript Second resubmission Final.docx - Accepted Version

Download (272kB)
[thumbnail of Figure 2A Unadjusted adjusted revised2.tif]
Figure 2A Unadjusted adjusted revised2.tif - Accepted Version

Download (1MB) | Preview
[thumbnail of Figure 2B T1DM T2DM revised.tif]
Figure 2B T1DM T2DM revised.tif - Accepted Version

Download (1MB) | Preview
[thumbnail of Supplement.docx] Text
Supplement.docx - Accepted Version

Download (13MB)
[thumbnail of wu_gold_springer_diabet_2016.pdf]
wu_gold_springer_diabet_2016.pdf - Published Version
Available under License Creative Commons Attribution.

Download (611kB) | Preview


Aims/hypothesis: Pre-eclampsia is a pregnancy-specific multi-system disorder and a state of physiological insulin resistance. Our aim is to systematically evaluate and quantify the evidence on the relationship between pre-eclampsia and the future risk of diabetes. Methods: We conducted a systematic review and meta-analysis of studies that evaluated diabetes in women with and without pre-eclampsia. We performed a systematic search of MEDLINE and EMBASE to identify relevant studies. Independent double data extractions were conducted by four reviewers. Random effects meta-analysis was used to estimate the risk of future diabetes following pre-eclampsia. Results: Twenty-one studies were identified with over 2.8 million women including >72,000 women with pre-eclampsia. Meta-analysis of studies that adjusted for potential confounders demonstrated that pre-eclampsia was independently associated with an increased risk of future diabetes (risk ratio (RR) 2.37, 95% CI 1.89, 2.97). This risk appeared in studies that followed up women from <1 year (RR 1.97, 95% CI 1.35, 2.87) and persisted to over 10 years post-partum (RR 1.95, 95% CI 1.28, 2.97). After adjusting for BMI or gestational diabetes, pre-eclampsia was linked with an increased risk of future diabetes (RR 2.38, 95% CI 1.74, 3.24) or (RR 2.36, 95% CI 1.94, 2.88), respectively. Conclusions/interpretation: Pre-eclampsia is independently associated with a two-fold increase in future diabetes. Our study highlights the importance of clinical risk assessment for the future development of diabetes in women with pre-eclampsia. We recommend detailed evaluation of a screening programme for diabetes in this high-risk population.

Item Type: Article
Uncontrolled Keywords: Diabetes mellitus, Meta-analysis, Pre-eclampsia, Risk predictors, Screening, Systematic review
Subjects: R Medicine > RC Internal medicine > RC648 Diseases of the endocrine glands. Clinical endocrinology.
R Medicine > RC Internal medicine > RC660 Diabetes
Divisions: Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine
Depositing User: Symplectic
Date Deposited: 04 Aug 2016 13:45
Last Modified: 26 Feb 2021 14:47
URI: https://eprints.keele.ac.uk/id/eprint/2098

Actions (login required)

View Item
View Item